Dr Brendan Shaw is the principal of Shawview Consulting, the former CEO of Medicines Australia and assistant director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a special comment, Dr Shaw discusses the recent focus on domestic manufacturing capability. …
New industrial policy for biopharmaceutical and devices industry needs careful thought
April 17, 2020 Latest NewsNews of the Day
Latest Video
New Stories
-
A mixed bag for the industry in Trump executive order on medicine pricing
April 17, 2025 - - Latest News -
Telix says IPAX-Linz study shows promising efficacy for glioma therapy candidate
April 16, 2025 - - Australian Biotech -
Prescient's PTX-100 receives US FDA Fast Track Designation
April 16, 2025 - - Australian Biotech -
Australian research finds turning off protein may help prevent liver cancer
April 16, 2025 - - Australian Biotech -
UQ tests vaccine response in CEPI-backed 150-day ‘moonshot’ challenge
April 16, 2025 - - Australian Biotech -
Cartherics announces board changes, including a new chair
April 16, 2025 - - Australian Biotech -
Astellas Pharma Australia appoints new head of medical affairs
April 16, 2025 - - Latest News